Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Cardamonin decreased the expression of lipogenic proteins. by Peiguang Niu (17044532)

Subjects:

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Cardamonin decreased the protein expression of lipogenic proteins. by Peiguang Niu (17044532)

Subjects:

The stimulation with FA or GW501516 decreases DNA damage. by Shota Tanaka (339198)

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. by Yingshi Ji (9013004)

CaMKKβ contributes to the decrease in apoptosis conferred by ST2-104. by Yingshi Ji (9013004)

Decreased spindle microtubules in CAMSAP2 KO cells. by Naoko Nishizawa (20536299)

Cardamonin induced apoptosis and decreased the MMP of ovarian cancer cells. by Peiguang Niu (17044532)

Subjects:

TH5487 decreases RSV replication in lungs. by Lang Pan (5145221)

Cardamonin decreased the content of free fatty acids and the activity of CPT-1. by Peiguang Niu (17044532)

Subjects:

Cardamonin decreased the protein level of Raptor and suppressed lipogenesis and CPT-1. by Peiguang Niu (17044532)

Subjects:

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

PBP1 depletion results in a population of cells with decreased RADA fluorescence. by Gregory A. Harrison (16639446)

“…A histogram depicting the percent of cells with the indicated amount of RADA fluorescence reveals that PBP1 depletion results in a population with decreased RADA signal. …”

Wnt signaling decreases the recruitment of RAB8a to basal bodies. by Cheng Yuan (160315)

Decreased cytokine expression in J2.2-HKU1.7b-infected BMDM. by Chaminda D. Gunawardene (22794593)

Knockdown of ATP2C1 results in a minor decrease of [Ca²⁺] in WPB. by Julian Terglane (12975565)

HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”